Publication by Guccini et al.: Inhibition of ketohexokinase C isoform impairs the development of PDAC tumors.

Guccini et al. showed that ketohexokinase, the rate-limiting enzyme of fructose metabolism, is a driver of pancreatic ductal adenocarcinoma (PDAC) development.